Sun Pharma initiates Phase II clinical trial on AQCH, a potential COVID-19 drug
Sun Pharmaceutical Industries had initiates Phase II clinical trial on AQCH, a phytopharmaceutical drug, as a potential treatment for COVID-19 patients. The company had received approval from the Drugs Controller General of India (DCGI) for conducting the Phase II clinical trial in April this year.Get latest Healthcare online at cnbctv18.com